Shareholder Votes

Evercore Inc. shareholders approved Approval of Fourth Amended and Restated 2016 Evercore Inc. Stock Incentive Plan at the 2026-06-10 meeting.

“4. The Fourth Amended and Restated 2016 Evercore Inc. Stock Incentive Plan was approved based on the following final tabulation of votes: For 23,832,129 Against 11,204,040 Abstain 15,941 Broker non-votes 2,988,968”

Evercore Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as Evercore’s independent registered public accounting firm for 2026 at the 2026-06-10 meeting.

“3. The appointment of Deloitte & Touche LLP as Evercore’s independent registered public accounting firm for 2026 was ratified, based upon the following final tabulation of votes: For 37,463,916 Against 569,791 Abstain 7,371 Broker non-votes N/A”

Evercore Inc. shareholders approved Non-binding advisory vote to approve executive compensation of Evercore’s named executive officers at the 2026-06-10 meeting.

“2. The non-binding, advisory vote to approve executive compensation of Evercore’s named executive officers (“say-on-pay”) was approved based upon the following final tabulation of votes: For 32,994,941 Against 2,026,114 Abstain 31,055 Broker non-votes 2,988,968”

Evercore Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“Item 5.07 Submission of Matters to a Vote of Security Holders. (a) Evercore Inc. (“Evercore”) held its annual meeting of stockholders on June 10, 2026. (b) Stockholders voted on the matters set forth below. 1. The nominees for election to the Board of Directors were elected to serve as directors until the next Annual Meeting or until their successors are duly elected and qualified, based upon the following final tabulation of votes: Roger C. Altman For 34,441,446 Against 601,205 Abstain 9,459 Broker non-votes 2,988,968”

Theravance Biopharma, Inc. shareholders approved Non-binding advisory resolution regarding the compensation of the Company’s named executive officers at the 2026-06-12 meeting.

“Proposal Three – Based on the following results of voting, a non-binding advisory resolution regarding the compensation of the Company’s named executive officers was approved: For Against Abstain Broker Non-Votes 42,631,324 221,196 51,183 4,156,175”

Theravance Biopharma, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-12 meeting.

“Proposal Two – Based on the following results of voting, the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified: For Against Abstain Broker Non-Votes 46,471,340 572,896 15,642 —”

Theravance Biopharma, Inc. shareholders approved Election of Directors at the 2026-06-12 meeting.

“Proposal One – Based on the following results of voting, the nominees listed below were elected directors to serve as members of the Board until the Company’s Annual General Meeting held in 2027 and until their successors are duly elected and qualified: Nominees For Against Abstain Broker Non-Votes Laurie Smaldone Alsup 42,725,649 124,187 53,867 4,156,175 Susannah Gray 42,231,530 618,306 53,867 4,156,175 Dean J. Mitchell 42,557,257 297,316 49,130 4,156,175 Donal O’Connor 42,535,463 319,110 49,130 4,156,175 Deepika R. Pakianathan 41,936,019 918,543 49,141 4,156,175 Rick E Winningham 42,474,538 377,274 51,891 4,156,175”

BigBear.ai Holdings, Inc. shareholders approved Approval of Amendment to the Company’s Certificate of Incorporation to increase authorized shares at the 2026-06-09 meeting.

“The vote to approve an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock of the Company from 500,000,000 to 1,000,000,000 was approved. Votes For Votes Against Abstentions Broker Non-Votes 241,570,296 27,077,068 3,082,561 —”

BigBear.ai Holdings, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“The appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified. Votes For Votes Against Abstentions Broker Non-Votes 265,572,995 3,510,898 2,646,032 —”

BigBear.ai Holdings, Inc. shareholders approved Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2026-06-09 meeting.

“The Company’s shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2025. Votes For Votes Against Abstentions Broker Non-Votes 86,606,157 9,573,649 2,797,420 172,752,699”

BigBear.ai Holdings, Inc. shareholders approved Advisory Vote on the Frequency of the Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2026-06-09 meeting.

“The Company’s shareholders approved a 1-year voting frequency, on a non-binding advisory basis, as the frequency of future non-binding advisory votes on the compensation of our named executive officers, by the votes set forth below: Frequency Votes Submitted Abstentions Broker Non-Votes 1 Year 92,842,228 2,411,711 172,752,699”

BigBear.ai Holdings, Inc. shareholders approved Election of Class II directors at the 2026-06-09 meeting.

“The Company’s shareholders elected the following nominees for director to serve as Class II directors for a three-year term expiring in 2029 or until their successors shall have been elected and qualified. Name Votes For Votes Withheld Broker Non-Votes Kevin McAleenan 89,446,324 9,530,902 172,752,699 Pamela Braden 81,006,003 17,971,223 172,752,699”

Lument Finance Trust, Inc. shareholders approved Ratify the appointment of KPMG, LLP as LFT’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“The voting results of the proposal to ratify the appointment of KPMG, LLP as LFT’s independent registered public accounting firm for the fiscal year ending December 31, 2026, were as follows: Shares For Shares Against Abstentions Broker Non-Votes 42,151,558 1,302,421 323,536 N/A”

Lument Finance Trust, Inc. shareholders approved Approve, on an advisory basis, the compensation of the named executive officers of LFT, as described in the proxy statement for the Annual Meeting at the 2026-06-10 meeting.

“The voting results of the proposal to approve, on an advisory basis, the compensation of the named executive officers of LFT, as described in the proxy statement for the Annual Meeting, were as follows: Shares For Shares Against Abstentions Broker Non-Votes 30,819,599 3,781,895 319,335 8,856,686”

Lument Finance Trust, Inc. shareholders approved Re-elect James P. Flynn to the Board of Directors at the 2026-06-10 meeting.

“Nominee Shares For Shares Withheld Broker Non-Votes James P. Flynn 33,309,017 1,611,812 8,856,686”

Warby Parker Inc. shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. at the 2026-06-08 meeting.

“The compensation of the Company’s named executive officers was approved on an advisory (non-binding) basis.”

Warby Parker Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-08 meeting.

“The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Warby Parker Inc. shareholders approved Election of three Class II directors for a term expiring at the 2029 annual meeting. at the 2026-06-08 meeting.

“The stockholders elected each of the three persons named below as Class II directors to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified.”

Neuraxis, INC shareholders approved Approval of Neuraxis, Inc. 2025 Employee Stock Purchase Plan at the 2026-06-10 meeting.

“4. The proposal regarding the Neuraxis, Inc. 2025 Employee Stock Purchase Plan was approved as follows:”

Neuraxis, INC shareholders approved Amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan at the 2026-06-10 meeting.

“3. The proposal regarding the amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan was approved as follows:”

Neuraxis, INC shareholders approved Ratification of appointment of Rosenberg Rich Baker Berman, P.A. as independent registered public accounting firm at the 2026-06-10 meeting.

“2. The proposal to ratify the appointment of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as follows:”

Neuraxis, INC shareholders approved Election of six nominees for director at the 2026-06-10 meeting.

“1. The six nominees for director were elected to serve a one-year term as follows:”

BARFRESH FOOD GROUP INC. shareholders approved Approval and adoption of an amendment to the Company’s certificate of incorporation to increase the number of authorized shares of common stock to 35,000,000 at the 2026-06-11 meeting.

“Approval and adoption of amendment to certificate of incorporation 8,800,688 18,815 9,075”

BARFRESH FOOD GROUP INC. shareholders approved Ratification of the appointment of Eide Bailly LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Ratification and approval of the selection of Eide Bailly LLP 8,934,438 2,317 7,914”

BARFRESH FOOD GROUP INC. shareholders approved Election of six members of the board of directors at the 2026-06-11 meeting.

“At the annual meeting, all of the Company’s current directors were re-elected. The following is a summary of the votes cast at the annual meeting with respect to the election of directors: Name Votes in Favor Votes Against Riccardo Delle Coste 7,490,416 1,338,162 Steven Lang 7,579,535 1,249,043 Joseph M. Cugine 7,506,027 1,322,551 Alexander H. Ware 8,721,301 107,277 Marc Panvier 8,815,290 13,288 Tim Trant 8,793,828 34,750”

Fidelity National Information Services, Inc. shareholders approved Ratification of KPMG LLP as independent registered public accounting firm for 2026 at the 2026-06-10 meeting.

“The Company’s shareholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for 2026, with 438,020,543 votes for, 25,510,333 votes against and 1,811,710 abstentions.”

Fidelity National Information Services, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-10 meeting.

“The Company’s shareholders approved, on an advisory and non-binding basis, the compensation of the Company’s named executive officers, with 301,711,970 votes for, 125,371,576 votes against, 1,330,746 abstentions and 36,928,294 broker non-votes.”

Fidelity National Information Services, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.

“The Company’s shareholders elected all persons nominated as directors to serve until the Company’s 2027 Annual Meeting of Shareholders, as set forth in the Proxy Statement, with the following voting results:”

Praxis Precision Medicines, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-10 meeting.

“The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 24,054,017 824,318 29,929 1,815,967”

Praxis Precision Medicines, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

“The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows: Votes For Votes Against Abstain Broker Non-Vote 26,667,376 39,285 17,570 0”

Praxis Precision Medicines, Inc. shareholders approved Election of Class III Directors at the 2026-06-10 meeting.

“The Company’s stockholders elected Gregory Norden, Marcio Souza and William Young to serve as Class III members of the Board of Directors of the Company until the Company’s 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal, with the votes cast as follows: Class III Director Nominees Votes For Votes Withheld Broker Non-Vote Gregory Norden 24,597,327 310,937 1,815,967 Marcio Souza 24,771,396 136,868 1,815,967 William Young 21,293,535 3,614,729 1,815,967”

Enovix Corp shareholders approved Ratification of Appointment of Independent Registered Accounting Firm for Fiscal Year 2025 at the 2026-06-11 meeting.

“Proposal 3 – Ratification of Appointment of Independent Registered Accounting Firm for Fiscal Year 2025 Stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 3, 2027.”

Enovix Corp shareholders approved Compensation of Our Named Executive Officers at the 2026-06-11 meeting.

“Proposal 2 – Compensation of Our Named Executive Officers Stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.”

Enovix Corp shareholders approved Election of Directors at the 2026-06-11 meeting.

“Proposal 1 – Election of Directors Stockholders approved the election of each of the Company’s eight (8) directors to serve for a one-year term until the Company’s 2027 Annual Meeting of Stockholders.”

Falcon's Beyond Global, Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Our stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Falcon's Beyond Global, Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.

“Our stockholders elected Gino P. Lucadamo and Cecil D. Magpuri as Class III directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.”

MERCADOLIBRE INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.

“Proposal Three — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain 42,608,235 283,482 26,069 There were no broker non-votes associated with the ratification of the appointment of our independent registered public accounting firm.”

MERCADOLIBRE INC shareholders approved Advisory Vote on the Compensation of our Named Executive Officers at the 2026-06-09 meeting.

“Proposal Two — Advisory Vote on the Compensation of our Named Executive Officers: For Against Abstain 34,371,581 4,445,767 232,286 In addition, there were 3,868,152 broker non-votes associated with the advisory vote on the compensation of our named executive officers.”

MERCADOLIBRE INC shareholders approved Election of Class I Directors at the 2026-06-09 meeting.

“Proposal One — Election of Class I Directors: Nominee for Class I Directors For Withheld Susan Segal 36,780,151 2,269,483 Stelleo Passos Tolda 13,399,536 25,650,098 Alejandro Nicolás Aguzin 38,488,792 560,842 In addition, there were 3,868,152 broker non-votes associated with the election of the Class I directors.”

TG THERAPEUTICS, INC. shareholders rejected Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal 3 The advisory vote to approve the compensation of the Company’s named executive officers was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 31,905,837 48,858,169 668,903 31,570,505”

TG THERAPEUTICS, INC. shareholders approved Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 2 The vote with respect to the ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 112,329,330 531,758 142,326 --”

TG THERAPEUTICS, INC. shareholders approved Election of six directors to hold office until the 2027 annual meeting at the 2026-06-11 meeting.

“Proposal 1 The votes with respect to the election of the six directors to hold office until the 2027 annual meeting were as follows: Director Votes For % Voted For Votes Withheld % Voted Withheld Broker Non-Votes Michael S. Weiss 72,172,630 88.63% 9,260,279 11.37% 31,570,505 Laurence N. Charney 68,135,448 83.67% 13,297,461 16.33% 31,570,505 Yann Echelard 64,110,661 78.73% 17,322,248 21.27% 31,570,505 Kenneth Hoberman 53,354,717 65.52% 28,078,192 34.48% 31,570,505 Daniel Hume 63,979,535 78.57% 17,453,374 21.43% 31,570,505 Sagar Lonial, MD 44,666,544 54.85% 36,766,365 45.15% 31,570,505”

Lineage Cell Therapeutics, Inc. shareholders approved Advisory vote on the compensation paid to the Company’s named executive officers at the 2026-06-10 meeting.

“3. Shareholders approved, on an advisory basis, the compensation paid to the Company’s named executive officers, as set forth in the Proxy Statement, by the following votes:”

Lineage Cell Therapeutics, Inc. shareholders approved Ratification of Baker Tilly US, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“2. Shareholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 by the following votes:”

Lineage Cell Therapeutics, Inc. shareholders approved Election of seven nominees to the board of directors at the 2026-06-10 meeting.

“1. Shareholders elected the seven nominees named below to the Company’s board to hold office until the Company’s 2027 annual meeting of shareholders and until their respective successors are duly elected and qualified by the following votes:”

Live Nation Entertainment, Inc. shareholders approved Ratification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for 2026 at the 2026-06-11 meeting.

“Ernst & Young LLP was ratified as the Company’s independent registered public accounting firm for the 2026 fiscal year”

Live Nation Entertainment, Inc. shareholders approved Advisory Vote on the Company's Executive Compensation at the 2026-06-11 meeting.

“1 – Election of Directors Nominees For Against Abstained Broker Non-Votes Maverick Carter 193,131,921 23,431,634 2,228,673 7,660,607 Ping Fu 215,754,598 938,407 2,099,224 7,660,607 Richard Grenell 216,356,981 343,049 2,092,198 7,660,607 Jeff Hinson 213,754,936 2,938,042 2,099,250 7,660,607 Chad Hollingsworth 205,632,367 11,060,956 2,098,905 7,660,607 Jimmy Iovine 213,140,054 3,555,950 2,096,224 7,660,607 Jim Kahan 214,090,873 2,604,761 2,096,594 7,660,607 Randall Mays 210,256,317 6,439,615 2,096,296 7,660,607 Rich Paul 216,151,092 544,423 2,096,713 7,660,607 Michael Rapino 216,029,451 666,395 2,096,382 7,660,607 Carl Vogel 216,232,558 460,545 2,099,125 7,660,607 Latriece Watkins 213,131,010 3,488,644 2,172,575 7,660,607 Proposal No.”

Live Nation Entertainment, Inc. shareholders approved Election of Directors at the 2026-06-11 meeting.

“Maverick Carter, Ping Fu, Richard Grenell, Jeff Hinson, Chad Hollingsworth, Jimmy Iovine, Jim Kahan, Randall Mays, Rich Paul, Michael Rapino, Carl Vogel, and Latriece Watkins were elected as directors”

Stagwell Inc shareholders approved Ratification of selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm. The stockholders ratified the selection of PricewaterhouseCoopers LLP to act as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the votes shown below. For Against Abstain 231,947,554 30,140 3,409”

Stagwell Inc shareholders approved Advisory approval of 2025 executive compensation at the 2026-06-11 meeting.

“Proposal 2 - Executive Compensation. The stockholders approved, on a non-binding, advisory basis, the 2025 executive compensation of the Company’s named executive officers by the votes shown below. For Against Abstain Broker Non-Votes 213,503,614 3,763,867 291,216 14,422,406”